Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Receivables - Net: 2020-2024

Historic Receivables - Net for Biofrontera (BFRI) over the last 5 years, with Dec 2024 value amounting to $5.3 million.

  • Biofrontera's Receivables - Net fell 38.55% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 38.55%. This contributed to the annual value of $5.3 million for FY2024, which is 2.96% up from last year.
  • Latest data reveals that Biofrontera reported Receivables - Net of $5.3 million as of FY2024, which was up 2.96% from $5.2 million recorded in FY2023.
  • Biofrontera's 5-year Receivables - Net high stood at $5.3 million for FY2024, and its period low was $3.2 million during FY2020.
  • In the last 3 years, Biofrontera's Receivables - Net had a median value of $5.2 million in 2023 and averaged $4.7 million.
  • As far as peak fluctuations go, Biofrontera's Receivables - Net fell by 0.95% in 2022, and later soared by 37.73% in 2023.
  • Over the past 5 years, Biofrontera's Receivables - Net (Yearly) stood at $3.2 million in 2020, then grew by 17.66% to $3.8 million in 2021, then fell by 0.95% to $3.7 million in 2022, then spiked by 37.73% to $5.2 million in 2023, then increased by 2.96% to $5.3 million in 2024.